| Stage | AAON | % of rev | JCI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $627M | 100.00% | $6.6B | 100.00% | JCI ×10.55 |
| Gross profit | $152M | 24.32% | $2.5B | 37.41% | JCI +13.1pp |
| Operating income | $69M | 10.99% | $987M | 14.92% | JCI +3.9pp |
| Pre-tax income | $63M | 10.02% | $917M | 13.86% | JCI +3.8pp |
| Net income | $57M | 9.04% | $752M | 11.37% | JCI +2.3pp |
| Stage | AAON | JCI | Gap · A − B |
|---|---|---|---|
| Revenue | $627M100.00% | $6.6B100.00% | JCI ×10.55 |
| Gross profit | 24.32%$152M | 37.41%$2.5B | JCI +13.1pp |
| Operating income | 10.99%$69M | 14.92%$987M | JCI +3.9pp |
| Pre-tax income | 10.02%$63M | 13.86%$917M | JCI +3.8pp |
| Net income |
| 9.04%$57M |
| 11.37%$752M |
| JCI +2.3pp |
No shared counterparties.